- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about FGEN
Recent news which mentions FGEN
From InvestorPlace
103 Biggest Movers From Yesterday
May 11, 2022
From Benzinga
From Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
May 10, 2022
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
20 Stocks Moving in Monday's Pre-Market Session
May 09, 2022
From Benzinga
From Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
February 28, 2022
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
FibroGen, inc (FGEN) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
FGEN
From Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 30, 2021
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
50 Biggest Movers From Yesterday
September 23, 2021
From Benzinga
Why FibroGen Fell by More Than 9% on Wednesday
September 22, 2021
From Motley Fool
32 Stocks Moving In Wednesday's Mid-Day Session
September 22, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021
September 22, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Friday
August 27, 2021
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
58 Biggest Movers From Friday
August 23, 2021
From Benzinga
38 Stocks Moving In Friday's Mid-Day Session
August 20, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.